Literature DB >> 31182182

Antimicrobial utilization data: Does point prevalence data correlate with defined daily doses?

Stephen B Lee1, Daniel J G Thirion2, Neal Irfan3, Melani Sung1, Annie Brooks1, Fatimah Al-Mutawa1, Charles Frenette4, Dominik Mertz1.   

Abstract

We correlated antibiotic consumption measured by point prevalence survey with defined daily doses (DDD) across multiple hospitals. Point prevalence survey had a higher correlation (1) with monthly DDDs than annual DDDs, (2) in nonsurgical versus surgical wards, and (3) on high- versus low-utilization wards. Findings may be hospital specific due to hospital differences.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31182182     DOI: 10.1017/ice.2019.154

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  2 in total

1.  The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.

Authors:  Greg J German; Charles Frenette; Jean-Alexandre Caissy; Jennifer Grant; Marie-Astrid Lefebvre; Dominik Mertz; Sarah Lutes; Allison McGeer; Jacqueline Roberts; Kevin Afra; Louis Valiquette; Yannick Émond; Marie Carrier; Anaïs Lauzon-Laurin; Trong Tien Nguyen; Hamed Al-Bachari; Justin Kosar; Shaqil Peermohamed; Michelle Science; Daniel Landry; Timothy MacLaggan; Peter Daley; Gerald McDonald; Anita Ang; Sandra Chang; Yu-Chen Lin; Brandon Tong; Suzanne Malfair; Victor Leung; Kevin Katz; Ines Pauwels; Herman Goossens; Ann Versporten; John Conly; Daniel J G Thirion
Journal:  CMAJ Open       Date:  2021-12-21

2.  The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.

Authors:  Charles Frenette; David Sperlea; Greg J German; Kevin Afra; Jennifer Boswell; Sandra Chang; Herman Goossens; Jennifer Grant; Marie-Astrid Lefebvre; Allison McGeer; Dominic Mertz; Michelle Science; Ann Versporten; Daniel J G Thirion
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-11       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.